Peer-reviewedCC BYJACC. Advances
Gender and Racial Distribution of Transthyretin Stabilizer Therapy in Patients With Transthyretin Cardiac Amyloidosis.
- 1University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA. Electronic address: [email protected].
- 2University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Related
- Effect of Transthyretin Stabilizer in Transthyretin Cardiac Amyloidosis
- Transcatheter Mitral Edge-to-edge Repair in Patients with Transthyretin Cardiac Amyloidosis: A Four-case Series
- Taurine is a functional regulator of transthyretin; implication in transthyretin-induced hypothyroidism and amyloidosis
- A Progressive 99mTc-MDP Uptake in Transthyretin Cardiac Amyloidosis
- The Progressive Cardiac Uptake of 99mTc-MDP as a Clue to Transthyretin Amyloidosis
BibTeX
@article{foley2026gender,
title = {{Gender and Racial Distribution of Transthyretin Stabilizer Therapy in Patients With Transthyretin Cardiac Amyloidosis.}},
author = {Stephen J Foley and Shruti Hegde},
journal = {JACC. Advances},
year = {2026},
month = oct,
doi = {10.1016/j.jacadv.2026.103201},
url = {https://europepmc.org/article/MED/42910804},
note = {CC BY},
}
RIS
TY - JOUR
TI - Gender and Racial Distribution of Transthyretin Stabilizer Therapy in Patients With Transthyretin Cardiac Amyloidosis.
AU - Stephen J Foley
AU - Shruti Hegde
PY - 2026
DA - 2026/10/01
JO - JACC. Advances
DO - 10.1016/j.jacadv.2026.103201
UR - https://europepmc.org/article/MED/42910804
SN - 2772-963X
ER -